A detailed history of Cromwell Holdings LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cromwell Holdings LLC holds 233 shares of REGN stock, worth $173,468. This represents 0.16% of its overall portfolio holdings.

Number of Shares
233
Previous 233 -0.0%
Holding current value
$173,468
Previous $244,000 -0.0%
% of portfolio
0.16%
Previous 0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $205,785 - $249,587
233 New
233 $244,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.